Oseltamivir-Associated Supraventricular Tachycardia in a Neonate
The Journal of Pediatric Pharmacology and Therapeutics · 15.06.2026
DOI: 10.5863/jppt-25-00098 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pediatric Pharmacology and Therapeutics, erschienen am 15.06.2026. Verfasst von Elif Duygu Kutbe und 4 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
The most common type of tachyarrhythmia in neonates is supraventricular tachycardia (SVT), which affects 1:250 to 1000 children and usually appears in the first year of life. Although some patients are asymptomatic, others may present with poor feeding, rapid breathing, and irritability. If left untreated, the condition can progress to heart failure and cardiogenic shock. This report describes a 20-day-old male neonate who developed SVT while receiving oseltamivir treatment for influenza and recovered with adenosine treatment. It also highlights the importance of avoiding possible triggers, early diagnosis, and treatment of SVT in neonates.
Zitieren
APA
Kutbe, E. D., Pur, H., Sonmez, E., Vural, C., & Baykan, A. (2026). Oseltamivir-Associated Supraventricular Tachycardia in a Neonate. The Journal of Pediatric Pharmacology and Therapeutics. https://doi.org/10.5863/jppt-25-00098
Vancouver
Kutbe ED, Pur H, Sonmez E, Vural C, Baykan A. Oseltamivir-Associated Supraventricular Tachycardia in a Neonate. The Journal of Pediatric Pharmacology and Therapeutics. 2026. doi:10.5863/jppt-25-00098
BibTeX
@article{Kutbe2026,
author = {Kutbe, Elif Duygu and Pur, Huseyin and Sonmez, Erhan and Vural, Cagdas and Baykan, Ali},
title = {Oseltamivir-Associated Supraventricular Tachycardia in a Neonate},
journal = {The Journal of Pediatric Pharmacology and Therapeutics},
year = {2026},
doi = {10.5863/jppt-25-00098}
}
EUVIMED